The SARS-CoV-2 Antigen Test Card is an immunochromatography based one step in vitro test. It is designed for the rapid qualitative determination of SARS-CoV-2 virus antigen in nasopharyngeal swabs from individuals suspected of COVID-19.
- Sample type: nasal swab
- Time to result: 15-20 min
- Sensitivity: 96.77%
- Specificity: 99.20%
- Accuracy: 98.72%
The Rapid SARS-CoV-2 Antigen Test Card is manufactured in China by Xiamen Boson Biotech Co., Ltd. and was approved by Health Canada on August 5, 2021.